Tag: Chylothorax

Postoperative chyle leaks occur in up to 8% of head and neck surgeries and can lead to significant nutritional and metabolic complications. This article explores a key pharmacological treatment, explaining **how does octreotide help with chyle leak** by reducing lymphatic fluid flow.

While primarily approved for specific hormone-secreting tumors like acromegaly and carcinoid syndrome, the somatostatin analogue **Sandostatin** is widely utilized for numerous off-label purposes across various medical disciplines. This practice, though common and evidence-based, means it is used for conditions other than those formally reviewed and sanctioned by the Food and Drug Administration (FDA).